Sofinnova Partners vet Tordjman launches Jeito with €200M first biotech fund
Paris-based Jeito Capital launched Monday with the €200 million ($223.1 million) close of its first fund, which the firm will invest in 15 therapeutics start-ups, primarily in Europe.
Jeito founder and CEO Rafaèle Tordjman was a managing partner at Sofinnova Partners, where she managed €1.5 billion in assets. ...